3.07
0.10 (3.37%)
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Bearish | Bullish |
Biotechnology (Global) | Bearish | Bullish | |
Stock | Allogene Therapeutics, Inc. | Bearish | Bearish |
Analyst Consensus
4 Buy, 1 Hold
Avg. Price @ Call: 3.74
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Value |
52 Weeks Range |
2.23 - 6.89
|
|
Price Target Range | ||
High | 17.00 (Truist Securities, 453.75%) | Buy |
Median | 9.00 (193.16%) | |
Low | 4.60 (Stifel, 49.84%) | Hold |
Average | 8.15 (165.47%) | |
Total | 4 Buy, 1 Hold |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
HC Wainwright & Co. | 16 May 2024 | 9.00 (193.16%) | Buy | 2.98 |
19 Mar 2024 | 10.00 (225.73%) | Buy | 4.39 | |
Truist Securities | 15 May 2024 | 17.00 (453.75%) | Buy | 2.98 |
Stifel | 14 May 2024 | 4.60 (49.84%) | Hold | 2.96 |
RBC Capital | 15 Mar 2024 | 10.00 (225.73%) | Buy | 4.66 |
JP Morgan | 27 Feb 2024 | 8.00 (160.59%) | Buy | 5.14 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |